IsoRay Inc. (ISR)

0.45
0.02 3.70
AMEX : Health Technology
Prev Close 0.43
Open 0.44
Day Low/High 0.43 / 0.46
52 Wk Low/High 0.38 / 0.69
Volume 131.79K
Avg Volume 136.70K
Exchange AMEX
Shares Outstanding 55.10M
Market Cap 22.59M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

IsoRay Announces Preliminary Second Quarter F2018 Revenue Of $1.54 Million, 50% Year-over-Year Increase

IsoRay Announces Preliminary Second Quarter F2018 Revenue Of $1.54 Million, 50% Year-over-Year Increase

Revenue Increase Driven by Increasing Traction of New Sales Strategies in Prostate Brachytherapy

IsoRay Announces Case Report Publication Discussing Focal Radiation Treatment Of Brain Metastases With Cesium-131

IsoRay Announces Case Report Publication Discussing Focal Radiation Treatment Of Brain Metastases With Cesium-131

Possible Evidence of Paradigm Shift in the Radiation Treatment of Cancers Afflicting the Brain

IsoRay Announces Manufacturing And Supply Agreement With GT Medical Technologies For GammaTile™ Radiation Therapy System

IsoRay Announces Manufacturing And Supply Agreement With GT Medical Technologies For GammaTile™ Radiation Therapy System

10 Year Exclusive Agreement to Supply Proprietary Cesium-131 Seeds Embedded in Collagen Tiles

IsoRay Announces First Quarter Fiscal 2018 Financial Results

IsoRay Announces First Quarter Fiscal 2018 Financial Results

Revenue of $1.21 Million, 12% First Quarter-Over-First Quarter Increase, Gross Margin of 22%

IsoRay Announces Preliminary Fourth Quarter F2017 Revenue Of $1.37 Million, 22% Year-over-Year Increase

IsoRay Announces Preliminary Fourth Quarter F2017 Revenue Of $1.37 Million, 22% Year-over-Year Increase

Gross Margin Expands Significantly to 31% on Ongoing Process Improvements and Expense Reduction

New Study Shows Brachytherapy And Cesium-131 Isotope Treatment Beneficial For Prostate Cancer Patients

New Study Shows Brachytherapy And Cesium-131 Isotope Treatment Beneficial For Prostate Cancer Patients

Medical community still battles acceptance of patient-friendly solution with proven reduced side effects and long-term symptoms

IsoRay Receives FDA Response To 510(k) Application For GammaTile™

IsoRay Receives FDA Response To 510(k) Application For GammaTile™

Additional Testing for GammaTile™ Planned for Completion by Year-End 2017

Insider Trading Alert - STRP, ISR And TCRD Traded By Insiders

Insider Trading Alert - STRP, ISR And TCRD Traded By Insiders

Stocks with insider trader activity include STRP, ISR and TCRD

Insider Trading Alert - ISR, AAT And FB Traded By Insiders

Insider Trading Alert - ISR, AAT And FB Traded By Insiders

Stocks with insider trader activity include ISR, AAT and FB

Insider Trading Alert - ISR, SIX And SUMR Traded By Insiders

Insider Trading Alert - ISR, SIX And SUMR Traded By Insiders

Stocks with insider trader activity include ISR, SIX and SUMR

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of IsoRay, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of July 21, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of IsoRay, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of July 21, 2015

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of IsoRay, Inc.

Glancy Prongay & Murray LLP Reminds Investors Of The Upcoming Deadline In The Class Action Filed On Behalf Of IsoRay, Inc. Investors

Glancy Prongay & Murray LLP Reminds Investors Of The Upcoming Deadline In The Class Action Filed On Behalf Of IsoRay, Inc. Investors

Glancy Prongay & Murray LLP announces that a class action complaint has been filed on behalf of a class comprising purchasers of the securities of IsoRay, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of IsoRay, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of July 21, 2015

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of IsoRay, Inc. Of Pendency Of Class Action Lawsuit And A Lead Plaintiff Deadline Of July 21, 2015

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of IsoRay, Inc.

IsoRay Investors Alert: Lieff Cabraser Reminds Investors Of July 21, 2015 Deadline In Class Action Litigation - ISR

IsoRay Investors Alert: Lieff Cabraser Reminds Investors Of July 21, 2015 Deadline In Class Action Litigation - ISR

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased or...

ISORAY INVESTORS: Lieff Cabraser Reminds Investors Of Upcoming Deadline In Class Action Litigation - ISR

ISORAY INVESTORS: Lieff Cabraser Reminds Investors Of Upcoming Deadline In Class Action Litigation - ISR

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased or...

Strong On High Volume: IsoRay (ISR)

Strong On High Volume: IsoRay (ISR)

Trade-Ideas LLC identified IsoRay (ISR) as a strong on high relative volume candidate

EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against IsoRay, Inc.

EQUITY ALERT: The Rosen Law Firm Files Securities Class Action Against IsoRay, Inc.

The Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of IsoRay, Inc.

Trade-Ideas: IsoRay (ISR) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas: IsoRay (ISR) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified IsoRay (ISR) as a "dead cat bounce" (down big yesterday but up big today) candidate

Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!

Biotech Stock Mailbag: ASCO Preview, CAR-T stocks, MannKind, Hate Mail!

Biotech columnist Adam Feuerstein answers readers' questions about health care.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Law Violations By The Board Of IsoRay, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Law Violations By The Board Of IsoRay, Inc.

Levi & Korsinsky announces it has commenced an investigation of IsoRay, Inc.

TheStreet Quant Rating: D- (Sell)